Table 1 General characteristics of indigenous people living with HIV from Condorcanqui and Bagua provinces - Amazonas Region
Characteristics | n (%) |
|---|---|
Age (years-old) a | 25 (22–32) |
Gender | |
Female | 89 (42.8) |
Male | 119 (57.2) |
District c | |
1 | 76 (36.5) |
2 | 74 (35.6) |
3 | 38 (18.3) |
4 | 20 (9.6) |
Ethnic group | |
Awajun | 185 (88.9) |
Wampis | 20 (9.6) |
Others | 3 (1.4) |
Marital status | |
Married | 10 (4.8) |
Single | 90 (43.3) |
With partner (non-married) | 94 (45.2) |
Divorced | 6 (2.9) |
Widower | 8 (3.4) |
Educational level | |
Without studies | 10 (4.8) |
Primary level | 44 (21.2) |
Secondary level | 130 (62.5) |
Superior studies | 24 (11.5) |
Occupational status | |
Other jobs | 91 (43.8) |
Agriculture | 60 (28.8) |
Employed | 26 (12.5) |
Student | 20 (9.6) |
Laborer | 10 (4.8) |
Hunting or fishing | 1 (0.5) |
Religion | |
Evangelic | 86 (41.3) |
Non-religious | 38 (18.3) |
Christian | 34 (16.3) |
Catholic | 22 (10.6) |
Israelite religión | 6 (2.9) |
Other | 22 (10.6) |
Income (S/.) a | 300 (100–500) |
Yes | 109 (52.4) |
Not | 99 (47.6) |
Alcohol use b | |
Yes | 47 (22.6) |
Not | 161 (77.4) |
Tobacco use b | |
Yes | 16 (7.7) |
Not | 192 (92.3) |
Drug or illicit substance use b | |
Yes | 3 (1.4) |
Not | 205 (98.6) |
People who are living with | |
With family | 174 (83.7) |
Alone and far to the family | 21 (10.1) |
Alone but close to the family | 13 (6.2) |
Travelling frequently to the cities? | |
Yes | 99 (47.6) |
Not | 109 (52.4) |
Risk group | |
MSM | 35 (16.8) |
TG | 4 (1.9) |
TS | 2 (1.0) |
PG | 167 (80.3) |
Disease time (days) | 1324.5 (417.8–1890.0) |
Opportunistic diseases | |
Yes | 50 (24.0) |
Not | 158 (76.0) |
Clinical stage (CS) | |
CS1 | 196 (94.2) |
CS2 | 9 (4.3) |
CS3 | 3 (1.4) |
CS4 | 0 (0.0) |
TB-HIV coinfection | |
Yes | 4 (1.9) |
Not | 204 (98.1) |
Type of treatment | |
Only ART | 152 (73.1) |
Only with medicinal plants | 9 (4.3) |
ART and medicinal plants | 39 (18.8) |
Self-medication | 8 (3.8) |
Therapeutic scheme | |
First line | 83 (39.9) |
Tenofovir based | 78 (37.5) |
Abacavir based | 0 (0.0) |
Zidovudine based | 3 (1.4) |
Does not know/ Not answer | 44 (21.2) |
Therapeutic time (days) | 1028 (361–1687) |
Adverse events to ART | |
Yes | 69 (33.2) |
Not | 139 (66.8) |
Health insurance | |
Not have | 10 (4.8) |
SIS | 189 (90.9) |
EsSalud | 9 (4.3) |
Transportation expenditures a | |
Not | 122 (58.7) |
Yes | 86 (41.3) |
Treatment expenditures | |
Not | 144 (69.2) |
Yes | 64 (30.8) |